Consultations in Psychiatry Through Videoconference

Remote Consultation [L01.178.847.652.550] Clinical Trial

Official title:

Consultations in Psychiatry Given to GP's Through Videoconference

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00274365
• Other study ID #: 4669ctil
• Status: Completed
• Phase: N/A
• First received: January 9, 2006
• Last updated: January 28, 2009
• Start date: November 2005
• Est. completion date: February 2007

Study information

• Verified date: April 2007
• Source: Sha’ar Menashe Mental Health Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Online consulatations through videoconference in the field of psychiatry given to general practitioners will reduce costs of medical treatment and improve service.

Description:

CLINICAL STATE, SATISFACTION AND COST EFFECTIVENESS WILL BE CHECKED DURING 1 YEAR OF ONLINE VIDEO CONFERENCE CONSULTATION TO GENERAL PRACTITIONERS. BPRS, HAMILTON ANXIETY AND DEPRESSION AND CGI SCALES WILL BE COMPLETED.COSTS OF MEDICATIONS, NUMBER OF VISITS, LAB AND OTHER EXAMINATIONS, HOSPITALIZATIONS, MISSING WORKING DAYS WILL BE EVALUATED.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: February 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Referral by general practitioner Age: >18 - Speaking Hebrew or Russion

Exclusion Criteria:

CGI>4 Dementia Drug or alcohol addiction -

Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Remote Consultation [L01.178.847.652.550]

Intervention

Procedure:
• videoconference

Locations

Country	Name	City	State
Israel	Regional clinic of General Health Services	Hadera

Sponsors (2)

Lead Sponsor	Collaborator
Sha’ar Menashe Mental Health Center	Galil Center for Telemedicine and Medical Informatics

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Expenditures on medications
Primary	No. of visits
Primary	Loss of work days
Primary	Expenditure on lab tests
Primary	Satisfaction
Primary	CGI
Primary	Hamilton
Primary	Somatisation
Primary	GHQ11
Primary	Q-LES-Q-18
Primary	No. of consultations